GeneTherapy.ISTH.org - Gene Therapy Latest News

Request for Proposals: Artificial Intelligence/Machine Learning Research in Hemophilia

Request for Proposals: Artificial Intelligence/Machine Learning Research in Hemophilia

06 August 2020

Spark Therapeutics Announces Updated Data on SPK-8011 from Phase 1/2 Clinical Trial in Hemophilia A at ISTH 2020 Virtual Congress

Spark Therapeutics Announces Updated Data on SPK-8011 from Phase 1/2 Clinical Trial in Hemophilia A at ISTH 2020 Virtual Congress

12 July 2020

Gene Therapy BAY 2599023 Showing Steady FVIII Activity, Safety in Trial

Gene Therapy BAY 2599023 Showing Steady FVIII Activity, Safety in Trial

24 July 2020

Freeline Raises $120M for Pivotal Trial of FLT180a, a Gene Therapy Candidate for Hemophilia B

Freeline Raises $120M for Pivotal Trial of FLT180a, a Gene Therapy Candidate for Hemophilia B

10 July 2020

Investigational Gene Therapy Results in Huge Drop in Bleeding Rates and Factor VIII Usage, Updated Data Show
24 June 2020
Efficacy of Gene Therapy SB-525 Now at 14 Months in Alta Hemophilia A Trial
19 June 2020
BioMarin’s Gene Therapy for Hemophilia A Continues to Prevent Bleeds After Four Years, Trial Shows
03 June 2020
FDA Agrees to Phase 1 Trial of ET3, Gene Therapy for Hemophilia A
27 May 2020

I agree with the Terms and conditions and the Privacy policy

About

Supported by educational grants from BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc

Essential SSL